Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-01-01 @ 9:17 AM
Study NCT ID:
NCT03481803
Status:
COMPLETED
Last Update Posted:
2018-09-28
First Post:
2018-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIa Study With Escalating Dose of MS1819-SD
Sponsor:
AzurRx SAS
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MS1819/16/01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None